HCWB
HCW Biologics Inc.
NASDAQ · USHealthcareBiotechnology
$3.83-4.25%
Price as of Jul 20, 2026
HCWB valuation
HCW Biologics Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1517.33x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.48x
- Price / sales
- 3.91x
- Price / cash flow
- -2.25x
Enterprise value
- Enterprise value
- $31.1M
- EV / sales
- 4.72x
- EV / EBITDA
- -51.51x
- EV / EBIT
- -4.83x
- Market cap
- $25.8M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.